CAS: 115043-27-1
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2H-1,4-Benzothiazin-3(4H)-one, 4-methyl-2-(1-methylethyl)-2-[2-[4-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]-1-piperazinyl]butoxy]phenyl]-, hydrochloride (1:2), (2R)- REF: IN-DA000FRDCAS: 115043-27-1 | - - - | A consultar | Qua 13 Nov 24 |
 | HOE-166 HCl REF: TM-T71371CAS: 115043-27-1 | - - - | 1.660,00 €~2.826,00 € | Qua 15 Jan 25 |
2H-1,4-Benzothiazin-3(4H)-one, 4-methyl-2-(1-methylethyl)-2-[2-[4-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]-1-piperazinyl]butoxy]phenyl]-, hydrochloride (1:2), (2R)-
CAS:115043-27-1
Fórmula:
C37H51Cl2N3O5S
Peso molecular:
720.7889 G/Mol
Ref: IN-DA000FRD
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 13 de Novembro de 2024
HOE-166 HCl
CAS:115043-27-1
HOE-166 HCl is a novel calcium receptor antagonist.
Fórmula:
C37H51Cl2N3O5S
Cor e Forma:
Solid
Peso molecular:
720.79
Ref: TM-T71371
| 25mg | 1.660,00 € | ||
| 50mg | 2.170,00 € | ||
| 100mg | 2.826,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 15 de Janeiro de 2025
